Vertebral Body Compression FracturesNCT01402167
Evaluating Vertebroplasty and Kyphoplasty for Reducing Trauma-related Fractures
A study testing Kyphoplasty and Vertebroplasty in people with Vertebral Body Compression Fractures, run by Centre Hospitalier Universitaire de Nīmes.
Trial summary
The primary objective of this study is to compare the volume of injected ciment (polymethyl methacrylate) between a group of patients treated with vertebroplasty and a group of patients treated via kyphoplasty. Read more about this study
- Who is it for?
- Ages 50 years and older
- Conditions the study is for
- Vertebral Body Compression Fractures
- What is being tested?
- Kyphoplasty and Vertebroplasty
- Type of treatment
- Surgery or procedure
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 0 participants
- Where
- No sites listed yet
- Study dates
- Sep 2014to Aug 2016
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 50 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- The patient must have given his/her informed and signed consent
- The patient must be insured or beneficiary of a health insurance plan
- The patient is available for 3 months of follow-up
- Fracture type according to Magerl Classification (1994) must be one of the following: A1, A2.1, A3.1, A3.2
- Cyphose of >10°
- Spinal pain
Show all 9Show fewer
- Vertebral fracture < 3 weeks old located between D5 and L5
- If fragments in the canal, they must protrude less than 40%
- Absence of other lesions, including cancer
Who cannot join
- The patient is participating in another study
- The patient is in an exclusion period determined by a previous study
- The patient is under judicial protection, under tutorship or curatorship
- The patient refuses to sign the consent
- It is impossible to correctly inform the patient
- Patient cannot read French
Show all 12Show fewer
- Patient is pregnant or breast feeding
- Patient has a fracture on an adjacent vertebra
- Patient has a contra-indication for a treatment used in this study
- ASA class IV or V
- Patient has a neurological deficit
- Previous spinal surgery
About this study
Official title: Evaluating Transcutaneous Vertebroplasty and Kyphoplasty for Reducing Trauma-related Fractures: a Randomized Pilot Study Using Catscan Volumetry
The primary objective of this study is to compare the volume of injected ciment (polymethyl methacrylate) between a group of patients treated with vertebroplasty and a group of patients treated via kyphoplasty. Secondary evaluation will compare the restoration of vertebral height, volume and cyphotic angle between the two techniques, as well as extravation of ciment and functional and quality of life aspects related to these techniques.
- Conditions
- Vertebral Body Compression Fractures
- Being tested
- Kyphoplasty, Vertebroplasty
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
KyphoplastyProcedure or surgery
Patients will be treated via a balloon kyphoplasty surgical procedure
VertebroplastyProcedure or surgery
Patients will be treated via a transcutaneous vertebroplasty procedure.
| Study group | Role | What they receive |
|---|---|---|
| Kyphoplasty | Experimental | Patients randomized to this arm will be treated via balloon kyphoplasty. Receives: Procedure: Kyphoplasty |
| Vertebroplasty | Active comparator | Patients randomized to this arm will be treated via vertebroplasty. Receives: Procedure: Vertebroplasty |
What is being measured
The primary outcome is the main question the study is designed to answer.
The volume (cm^3) of injected ciment
The volume of injected ciment is measured by catscan extrapolated data.
Measured: Baseline (Day 0)
Secondary outcomes (32)
Recovery of vertebral volume (%)
Recovery of vertebral volume relative to theoretical volume based on neighboring vertebra.
Measured: Day 1 to Day 7
Change from baseline of the cyphotic angle (°)
The number of degrees of change in the cyphotic angle of the corrected vertebra relative to baseline measurement (°)
Measured: Days 1 to 7
Change from baseline of the cyphotic angle (°)
The number of degrees of change in the cyphotic angle of the corrected vertebra relative to baseline measurement (°)
Measured: 1 month
Change from baseline of the cyphotic angle (°)
The number of degrees of change in the cyphotic angle of the corrected vertebra relative to baseline measurement (°)
Measured: 3 months
Change from baseline in vertebral height (mm)
Change in vertebra height (mm) before and after surgery
Measured: Days 1 to 7
Change from baseline in vertebral height (mm)
Change in vertebra height (mm) before and after surgery
Measured: 1 month
Change from baseline in vertebral height (mm)
Change in vertebra height (mm) before and after surgery
Measured: 3 months
Volume of ciment leakage (cm^3)
The volume of ciment leakage will be determined according to catscan data.
Measured: Day 1
Change in Visual Analog Scale (0 to 10) for pain before and after surgery
Brute change in Visual Analog Scale (0 to 10) for pain before and after surgery
Measured: Day 0 (post-op)
Change in Visual Analog Scale (0 to 10) for pain before and after surgery
Brute change in Visual Analog Scale (0 to 10) for pain before and after surgery
Measured: 1 month
Change in Visual Analog Scale (0 to 10) for pain before and after surgery
Brute change in Visual Analog Scale (0 to 10) for pain before and after surgery
Measured: 3 months
% Change in Visual Analog Scale (0 to 10) for pain before and after surgery
The percentage change (%) in Visual Analog Scale (0 to 10) for pain before and after surgery
Measured: Day 0 (post-op)
% Change in Visual Analog Scale (0 to 10) for pain before and after surgery
The percentage change (%) in Visual Analog Scale (0 to 10) for pain before and after surgery
Measured: 1 month
% Change in Visual Analog Scale (0 to 10) for pain before and after surgery
The percentage change (%) in Visual Analog Scale (0 to 10) for pain before and after surgery
Measured: 3 months
The change in the ODI score before and after surgery
The change in the Oswestry Disability Index before and after surgery
Measured: 3 months
The % change in the ODI score before and after surgery
The percentage change (%) in the Oswestry Disability Index before and after surgery
Measured: 3 months
Change in SF-36 quality of life score before and after surgery
Change in SF-36 quality of life score before and after surgery
Measured: 1 month
Change in SF-36 quality of life score before and after surgery
Change in SF-36 quality of life score before and after surgery
Measured: 3 months
The % change in SF-36 quality of life score before and after surgery
Percentage change (%) in SF-36 quality of life score before and after surgery
Measured: 1 month
The % change in SF-36 quality of life score before and after surgery
Percentage change (%) in SF-36 quality of life score before and after surgery
Measured: 3 months
Change in FABQ score before and after surgery
Change in the Fear-Avoidance Beliefs Questionnaire score before and after surgery
Measured: 1 month
Change in FABQ score before and after surgery
Change in the Fear-Avoidance Beliefs Questionnaire score before and after surgery
Measured: 3 months
% Change in FABQ score before and after surgery
Percentage change (%) in the Fear-Avoidance Beliefs Questionnaire score before and after surgery
Measured: 1 month
% Change in FABQ score before and after surgery
Percentage change (%) in the Fear-Avoidance Beliefs Questionnaire score before and after surgery
Measured: 3 months
Change in DPQ score before and after surgery
Change in the Dallas Pain Questionnaire score before and after surgery
Measured: 1 month
Change in DPQ score before and after surgery
Change in the Dallas Pain Questionnaire score before and after surgery
Measured: 3 months
% Change in DPQ score before and after surgery
Percentage change (%) in the Dallas Pain Questionnaire score before and after surgery
Measured: 3 months
% Change in DPQ score before and after surgery
Percentage change (%) in the Dallas Pain Questionnaire score before and after surgery
Measured: 1 month
Duration of surgery (minutes)
Length of operative time (minutes)
Measured: Day 0 (day of surgery)
Presence / absence of per-operative complications
Presence / absence of per-operative complications
Measured: Day 0 (day of surgery)
Presence / absence of post-operative complications
Presence / absence of post-operative complications
Measured: 1 month
Presence / absence of post-operative complications
Presence / absence of post-operative complications
Measured: 3 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted26 Jul 2011 (estimated)
- Study startSep 2014
- Primary completionMay 2016 (estimated)
- Study completionAug 2016 (estimated)
Why it stopped: Patients refuse randomization.
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Vertebral Body Compression FracturesStudies of the same condition, open and under way.
- More trials run by Centre Hospitalier Universitaire de NīmesThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind
- Who is masked
- Outcomes assessor
- Enrolment
- 0 participants (actual)
Sponsor and investigators
- Lead sponsor
- Centre Hospitalier Universitaire de Nīmes
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
- Investigators
- Pascal Kouyoumdjian, MD, Principal investigator, Centre Hospitalier Universitaire de Nīmes
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT01402167
- Sponsor's protocol ID
- LOCAL/2011/PK-04
- Status last verified
- Mar 2015
- First submitted
- 25 Jul 2011
- Last updated
- 16 Jun 2026
- Results posted
- No
- Data monitoring committee
- No
Study at a glance
From the registry record, last updated by the sponsor on 16 Jun 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Evaluating Transcutaneous Vertebroplasty and Kyphoplasty for Reducing Trauma-related Fractures: a Randomized Pilot Study Using Catscan Volumetry
- ClinicalTrials.gov ID
- NCT01402167
- Acronym / sponsor ID
- LOCAL/2011/PK-04
- Conditions
- Vertebral Body Compression Fractures
- Study type
- Interventional
- Recruitment status
- WithdrawnReason stopped: Patients refuse randomization.
- Enrolment
- 0 participants (actual)
- Lead sponsor
- Centre Hospitalier Universitaire de NīmesUniversity, hospital or other
- Study start
- Sep 2014
- Primary completion
- May 2016 (estimated)
- Study completion
- Aug 2016 (estimated)
- First posted
- 26 Jul 2011 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The primary objective of this study is to compare the volume of injected ciment (polymethyl methacrylate) between a group of patients treated with vertebroplasty and a group of patients treated via kyphoplasty. Secondary evaluation will compare the restoration of vertebral height, volume and cyphotic angle between the two techniques, as well as extravation of ciment and functional and quality of life aspects related to these techniques.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (outcomes assessor)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Kyphoplasty | Experimental | Procedure: KyphoplastyPatients randomized to this arm will be treated via balloon kyphoplasty. |
| Vertebroplasty | Active comparator | Procedure: VertebroplastyPatients randomized to this arm will be treated via vertebroplasty. |
Who may qualify
- Ages
- 50 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (9 listed)
- The patient must have given his/her informed and signed consent
- The patient must be insured or beneficiary of a health insurance plan
- The patient is available for 3 months of follow-up
- Fracture type according to Magerl Classification (1994) must be one of the following: A1, A2.1, A3.1, A3.2
- Cyphose of >10°
Key exclusion criteria (12 listed)
- The patient is participating in another study
- The patient is in an exclusion period determined by a previous study
- The patient is under judicial protection, under tutorship or curatorship
- The patient refuses to sign the consent
- It is impossible to correctly inform the patient
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| KyphoplastyPatients will be treated via a balloon kyphoplasty surgical procedure | Procedure or surgery | Kyphoplasty |
| VertebroplastyPatients will be treated via a transcutaneous vertebroplasty procedure. | Procedure or surgery | Vertebroplasty |
Primary outcome
The volume (cm^3) of injected ciment
Time frame: Baseline (Day 0)
The volume of injected ciment is measured by catscan extrapolated data.
32 secondary outcomes
Recovery of vertebral volume (%)
Time frame: Day 1 to Day 7
Change from baseline of the cyphotic angle (°)
Time frame: Days 1 to 7
Change from baseline of the cyphotic angle (°)
Time frame: 1 month
Change from baseline of the cyphotic angle (°)
Time frame: 3 months
Change from baseline in vertebral height (mm)
Time frame: Days 1 to 7
Change from baseline in vertebral height (mm)
Time frame: 1 month
Change from baseline in vertebral height (mm)
Time frame: 3 months
Volume of ciment leakage (cm^3)
Time frame: Day 1
Change in Visual Analog Scale (0 to 10) for pain before and after surgery
Time frame: Day 0 (post-op)
Change in Visual Analog Scale (0 to 10) for pain before and after surgery
Time frame: 1 month
Change in Visual Analog Scale (0 to 10) for pain before and after surgery
Time frame: 3 months
% Change in Visual Analog Scale (0 to 10) for pain before and after surgery
Time frame: Day 0 (post-op)
% Change in Visual Analog Scale (0 to 10) for pain before and after surgery
Time frame: 1 month
% Change in Visual Analog Scale (0 to 10) for pain before and after surgery
Time frame: 3 months
The change in the ODI score before and after surgery
Time frame: 3 months
The % change in the ODI score before and after surgery
Time frame: 3 months
Change in SF-36 quality of life score before and after surgery
Time frame: 1 month
Change in SF-36 quality of life score before and after surgery
Time frame: 3 months
The % change in SF-36 quality of life score before and after surgery
Time frame: 1 month
The % change in SF-36 quality of life score before and after surgery
Time frame: 3 months
Change in FABQ score before and after surgery
Time frame: 1 month
Change in FABQ score before and after surgery
Time frame: 3 months
% Change in FABQ score before and after surgery
Time frame: 1 month
% Change in FABQ score before and after surgery
Time frame: 3 months
Change in DPQ score before and after surgery
Time frame: 1 month
Change in DPQ score before and after surgery
Time frame: 3 months
% Change in DPQ score before and after surgery
Time frame: 3 months
% Change in DPQ score before and after surgery
Time frame: 1 month
Duration of surgery (minutes)
Time frame: Day 0 (day of surgery)
Presence / absence of per-operative complications
Time frame: Day 0 (day of surgery)
Presence / absence of post-operative complications
Time frame: 1 month
Presence / absence of post-operative complications
Time frame: 3 months
Results and safety
The study was withdrawn before enrolling participants, so there are no results.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 16 Jun 2026.
Related trials for Vertebral Body Compression Fractures
RecruitingObservational study
A Clinical Study to Collect Real-wordt Data on Safety and Clinical Performance of the VCFix Spinal System for Treatment of Vertebral Compression Fractures of (Suspected) Osteoporotic Origin.
Vertebra Compression Fracture
RecruitingObservational study
Prospective Evaluation of Therapeutic Combination in Treating Vertebral Compression Fractures
Vertebral Compression Fractures, Pathological Fracture
Active, not recruitingPhase 2
Cement Augmentation in Preventing Vertebral Body Compression Fracture Following Spine Stereotactic Radiosurgery in Patients With Solid Tumors and Spinal Metastases
Metastatic Malignant Neoplasm in the Spine, Metastatic Malignant Solid Neoplasm
Active, not recruiting
Sickle Cell Disease (SCD) Bone Pain Study
Sickle Cell Disease, Sickle Cell Anemia
Not yet recruitingObservational study
Large-Scale Evaluation of a Clinical Decision Tree for the Management of Low-Energy Thoracic and Lumbar Vertebral Compression Fractures.
Thoracolumbar Low-energy Vertebral Compression Fractures
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Pascal Kouyoumdjian, MD principal investigator
Centre Hospitalier Universitaire de Nīmes
Questions about this trial
What is this clinical trial studying?
A study testing Kyphoplasty and Vertebroplasty in people with Vertebral Body Compression Fractures, run by Centre Hospitalier Universitaire de Nīmes.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 9 inclusion and 12 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: withdrawn, as of the sponsor's last update on 16 Jun 2026. Status can change between updates, so confirm with the study contact before making plans.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study was withdrawn before enrolling participants, so there are no results.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
The volume (cm^3) of injected ciment (time frame: Baseline (Day 0)). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 16 Jun 2026.